Wei‐Li Ling
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
-
- HIV Research and Treatment
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 13
-
- Glycosylation and Glycoproteins Research 5
- Protein purification and stability 4
- Co-authors
- Samuel Ken‐En Gan (16 shared papers)Wai‐Heng Lua (12 shared papers)Chinh Tran-To Su (9 shared papers)Jun-Jie Poh (7 shared papers)Joshua Yi Yeo (9 shared papers)David P. Lane (3 shared papers)Anil Wipat (4 shared papers)Chandra Verma (1 shared paper)
- Journals
- Scientific Reports (3 papers)Frontiers in Immunology (3 papers)Antibodies (2 papers)Electrophoresis (1 paper)Cell Cycle (1 paper)
- Partner nations
- SingaporeUnited KingdomChina
In The Last Decade
Wei‐Li Ling
16 papers receiving 242 citations
Peers
Comparison fields: 5 of 49
- Radiology, Nuclear Medicine and Imaging 166
- Virology 20
- Immunology 82
- Immunology and Allergy 15
- Molecular Biology 158
Countries citing papers authored by Wei‐Li Ling
This map shows the geographic impact of Wei‐Li Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Li Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Li Ling more than expected).
Fields of papers citing papers by Wei‐Li Ling
This network shows the impact of papers produced by Wei‐Li Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Li Ling. The network helps show where Wei‐Li Ling may publish in the future.
Co-authors
The 12 scholars most cited alongside Wei‐Li Ling, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 45 | |
| 2 | 2018 | 36 | |
| 3 | 2018 | 31 | |
| 4 | 2017 | 23 | |
| 5 | 2020 | 20 | |
| 6 | 2019 | 20 | |
| 7 | 2016 | 14 | |
| 8 | 2020 | 11 | |
| 9 | 2021 | 9 | |
| 10 | 2022 | 8 | |
| 11 | 2020 | 7 | |
| 12 | 2015 | 6 | |
| 13 | 2022 | 4 | |
| 14 | 2022 | 4 | |
| 15 | 2017 | 4 | |
| 16 | 2019 | 1 |
About Wei‐Li Ling
Wei‐Li Ling is a scholar working on Radiology, Nuclear Medicine and Imaging, Molecular Biology, Immunology, Immunology and Allergy and Infectious Diseases, having authored 16 papers that have together received 243 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (13 papers), Glycosylation and Glycoproteins Research (5 papers), T-cell and B-cell Immunology (5 papers), Protein purification and stability (4 papers), Cell Adhesion Molecules Research (3 papers), HIV Research and Treatment (2 papers), HER2/EGFR in Cancer Research (2 papers) and HIV/AIDS drug development and treatment (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (166 citations), Virology (20 citations), Immunology (82 citations), Immunology and Allergy (15 citations) and Molecular Biology (158 citations). Wei‐Li Ling has collaborated with scholars based in Singapore, United Kingdom and China. Frequent co-authors include Samuel Ken‐En Gan, Wai‐Heng Lua, Chinh Tran-To Su, Jun-Jie Poh, Joshua Yi Yeo, David P. Lane, Anil Wipat, Chandra Verma, Birgit Eisenhaber and Peter J. Bond. Their work appears in journals such as Scientific Reports, Frontiers in Immunology, Antibodies, Electrophoresis and Cell Cycle.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.